Carregant...
SN38 loaded nanostructured lipid carriers (NLCs); preparation and in vitro evaluations against glioblastoma
SN38 is the active metabolite of irinotecan with 1000-fold greater cytotoxicity compared to the parent drug. Despite the potential, its application as a drug is still seriously limited due to its stability concerns and low solubility in acceptable pharmaceutical solvents. To address these drawbacks...
Guardat en:
| Publicat a: | J Mater Sci Mater Med |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8245372/ https://ncbi.nlm.nih.gov/pubmed/34191134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10856-021-06538-2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|